This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Kanaph Therapeutics Inc., Korea Research Institute of Chemical Technology. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 657 
Years Active: 2026
Title: Yeri Lee: Inventor in Pharmaceutical Research
Introduction
Yeri Lee is an inventor based in Seoul, South Korea. Her work includes research into compounds that inhibit the prostaglandin E2 receptor, a target relevant to pharmaceutical development.
Latest Patents
Lee is associated with 1 patent: “Compounds Having Inhibitory Activity on Prostaglandin E2 Receptor and Uses Thereof.” The patent describes a novel compound represented by Formula I, along with its solvates, stereoisomers, and pharmaceutically acceptable salts. It also addresses pharmaceutical compositions containing the compound and methods for using it.
Career Highlights
Lee has been associated with Kanaph Therapeutics Inc. and the Korea Research Institute of Chemical Technology. These organizations are connected to her work in chemical and pharmaceutical research.
Collaborations
Lee’s listed coworkers include Young Sook Shin and Sang Kyun Lim, reflecting collaborative work in the research and development of pharmaceutical inventions.
Conclusion
Yeri Lee’s patent activity centers on a proposed prostaglandin E2 receptor inhibitor and its potential pharmaceutical uses, within a career connected to research organizations in South Korea.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile